000 01491 a2200421 4500
005 20250515005931.0
264 0 _c20060404
008 200604s 0 0 eng d
022 _a0167-594X
024 7 _a10.1007/s11060-005-3666-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPinel, Sophie
245 0 0 _aTopotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts.
_h[electronic resource]
260 _bJournal of neuro-oncology
_cJan 2006
300 _a31-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease Progression
650 0 4 _aDose-Response Relationship, Radiation
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aGlioma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aTopotecan
_xadministration & dosage
650 0 4 _aTransplantation, Heterologous
700 1 _aChastagner, Pascal
700 1 _aMerlin, Jean-Louis
700 1 _aMarchal, Christian
700 1 _aTaghian, Alphonse
700 1 _aBarberi-Heyob, Muriel
773 0 _tJournal of neuro-oncology
_gvol. 76
_gno. 1
_gp. 31-8
856 4 0 _uhttps://doi.org/10.1007/s11060-005-3666-6
_zAvailable from publisher's website
999 _c15934697
_d15934697